Both DDX24 and TCERG1 were able to distinguish MS and OND patients (Fig 3); in particular, the difference between MS and OND CSF response in phage-ELISA was more statistically significant using DDX24 than TCERG1 peptide carrying clones. This evidence concerns the gene TCERG1 and myeloid sarcoma.